From: Antithrombotic drug removal with hemoadsorption during off-pump coronary artery bypass grafting
Variable | OPCAB + HA (n = 10) |
---|---|
Age, years | 67.4 ± 9.2 |
Gender, male | 8 (80) |
Prior PCI | 5 (50) |
Emergency indication (< 24 h) | 1 (10) |
Urgent indication | 9 (90) |
Acetylsalicylic acid | 10 (100) |
Ticagrelor | 8 (80) |
Rivaroxaban | 1 (10) |
Ticagrelor + rivaroxaban | 1 (10) |
NYHA functional class III/IV | 10 (100) |
Hypertension | 9 (90) |
Diabetes (NIDDM/IDDM) | 4/1 (34.2) |
Hyperlipidaemia | 10 (100) |
History of smoking | 6 (60) |
Renal dysfunction (creatinine ≥ 1.3 mg/dL / failure (dialysis) | 2 (80) |
Ejection fraction normal | 8 (20) |
Ejection fraction moderate impaired (40%; 45%) | 2 (20) |
BMI | 28,8 ± 4,3 |
BMI > 30 | 3 (30) |
EuroSCORE II, % | 2.9 ± 1.5 |